Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure.

Itzhaki Ben Zadok O, Kornowski R, Goldenberg I, Klempfner R, Toledano Y, Biton Y, Fisman EZ, Tenenbaum A, Golovchiner G, Kadmon E, Omelchenko A, Gal TB, Barsheshet A.

Cardiovasc Diabetol. 2017 Aug 14;16(1):102. doi: 10.1186/s12933-017-0582-y.

2.

Hypoxia and Hypoglycemia synergistically regulate mRNA stability.

Carraway KR, Johnson EM, Kauffmann TC, Fry NJ, Mansfield KD.

RNA Biol. 2017 Jul 3;14(7):938-951. doi: 10.1080/15476286.2017.1311456. Epub 2017 Mar 31.

3.

High incidence of abnormal glucose metabolism in acute coronary syndrome patients at a moderate altitude: A sub-Himalayan study.

Mokta J, Kumar S, Ganju N, Mokta K, Panda PK, Gupta S.

Indian J Endocrinol Metab. 2017 Jan-Feb;21(1):142-147. doi: 10.4103/2230-8210.196019.

4.

Effects of acute hyperglycaemia on cardiovascular homeostasis: does a spoonful of sugar make the flow-mediated dilatation go down?

Horowitz JD, Chong CR, Ngo DT, Sverdlov AL.

J Thorac Dis. 2015 Dec;7(12):E607-11. doi: 10.3978/j.issn.2072-1439.2015.12.40. No abstract available.

5.

Effects of Glucose Concentration on Propofol Cardioprotection against Myocardial Ischemia Reperfusion Injury in Isolated Rat Hearts.

Yao X, Li Y, Tao M, Wang S, Zhang L, Lin J, Xia Z, Liu HM.

J Diabetes Res. 2015;2015:592028. doi: 10.1155/2015/592028. Epub 2015 Sep 28.

6.
7.

Simple clinical risk score for no-reflow prediction in patients undergoing primary Percutaneous Coronary Intervention with acute STEMI.

Dogan NB, Ozpelit E, Akdeniz S, Bilgin M, Baris N.

Pak J Med Sci. 2015;31(3):576-81. doi: 10.12669/pjms.313.7484.

8.

Glycated Hemoglobin is a Better Predictor than Fasting Glucose for Cardiometabolic Risk in Non-diabetic Korean Women.

Yoon SR, Lee JH, Na GY, Seo YJ, Han S, Shin MJ, Kim OY.

Clin Nutr Res. 2015 Apr;4(2):97-103. doi: 10.7762/cnr.2015.4.2.97. Epub 2015 Apr 24.

9.

Interdisciplinary position statement on management of hyperglycemia in peri-operative and intensive care.

Bajwa SJ, Baruah MP, Kalra S, Kapoor MC.

J Anaesthesiol Clin Pharmacol. 2015 Apr-Jun;31(2):155-64. doi: 10.4103/0970-9185.155141. Review.

10.

Management of the hospitalized transplant patient.

Boerner B, Shivaswamy V, Goldner W, Larsen J.

Curr Diab Rep. 2015 Apr;15(4):19. doi: 10.1007/s11892-015-0585-6. Review.

11.

Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes.

Nolan CJ, Ruderman NB, Kahn SE, Pedersen O, Prentki M.

Diabetes. 2015 Mar;64(3):673-86. doi: 10.2337/db14-0694. Review.

12.

Association of inpatient and outpatient glucose management with inpatient mortality among patients with and without diabetes at a major academic medical center.

Butala NM, Johnson BK, Dziura JD, Reynolds JS, Bozzo JE, Balcezak TJ, Inzucchi SE, Horwitz LI.

J Hosp Med. 2015 Apr;10(4):228-35. doi: 10.1002/jhm.2321. Epub 2015 Jan 28.

13.

In-hospital daily insulin dose predicts long-term adverse outcome in patients with diabetes with ST-elevation myocardial infarction treated with successful primary percutaneous angioplasty.

Jeżewski T, Peruga JZ, Kasprzak JD, Bendinger T, Plewka M, Drożdż J, Drzewoski J, Krzeminska-Pakula M.

Arch Med Sci. 2014 Oct 27;10(5):913-9. doi: 10.5114/aoms.2014.46211. Epub 2014 Oct 23.

14.

Accuracy of point-of-care blood glucose measurements in critically ill patients in shock.

Garingarao CJ, Buenaluz-Sedurante M, Jimeno CA.

J Diabetes Sci Technol. 2014 Sep;8(5):937-44. doi: 10.1177/1932296814538608. Epub 2014 Jun 8.

15.

Conventional insulin vs insulin infusion therapy in acute coronary syndrome diabetic patients.

Arvia C, Siciliano V, Chatzianagnostou K, Laws G, Quinones Galvan A, Mammini C, Berti S, Molinaro S, Iervasi G.

World J Diabetes. 2014 Aug 15;5(4):562-8. doi: 10.4239/wjd.v5.i4.562.

16.

Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction.

Lazzeri C, Valente S, Chiostri M, D'Alfonso MG, Gensini GF.

World J Cardiol. 2014 Apr 26;6(4):140-7. doi: 10.4330/wjc.v6.i4.140. Review.

17.

[Assessment and treatment of hyperglycemia in critically ill patients].

Viana MV, Moraes RB, Fabbrin AR, Santos MF, Gerchman F.

Rev Bras Ter Intensiva. 2014 Jan-Mar;26(1):71-6. Review. Portuguese.

18.

Glycemic control in critically ill patients.

Hsu CW.

World J Crit Care Med. 2012 Feb 4;1(1):31-9. doi: 10.5492/wjccm.v1.i1.31. eCollection 2012 Feb 4. Review.

19.

Periprocedural glycemic control in patients with diabetes mellitus undergoing coronary angiography with possible percutaneous coronary intervention.

Shah B, Berger JS, Amoroso NS, Mai X, Lorin JD, Danoff A, Schwartzbard AZ, Lobach I, Guo Y, Feit F, Slater J, Attubato MJ, Sedlis SP.

Am J Cardiol. 2014 May 1;113(9):1474-80. doi: 10.1016/j.amjcard.2014.01.428. Epub 2014 Feb 12.

20.

Glycemic control and diabetes management in hospitalized patients in Brazil.

Moreira ED Jr, Silveira PC, Neves RC, Souza C Jr, Nunes ZO, Almeida Mda C; Brazilian Diabetes Investigators’ Group.

Diabetol Metab Syndr. 2013 Oct 18;5(1):62. doi: 10.1186/1758-5996-5-62.

Supplemental Content

Support Center